19 février 2009
NGX426
NGX426
First Multiple Dose Clinical Trial of TorreyPines Therapeutics’ Oral Compound NGX426 Demonstrates Compound is Safe and Well-Tolerated |
/https%3A%2F%2Fassets.over-blog.com%2Ft%2Fcedistic%2Fcamera.png)
Publicité
Commentaires
NGX426
First Multiple Dose Clinical Trial of TorreyPines Therapeutics’ Oral Compound NGX426 Demonstrates Compound is Safe and Well-Tolerated |